These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 11027968)

  • 1. Chlorination of harman and norharman with sodium hypochlorite and co-mutagenicity of the chlorinated products.
    Nakano K; Suyama K; Fukazawa H; Uchida M; Wakabayashi K; Shiozawa T; Terao Y
    Mutat Res; 2000 Oct; 470(2):141-6. PubMed ID: 11027968
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structures of mutagens produced by the co-mutagen norharman with o- and m-toluidine isomers.
    Hada N; Totsuka Y; Enya T; Tsurumaki K; Nakazawa M; Kawahara N; Murakami Y; Yokoyama Y; Sugimura T; Wakabayashi K
    Mutat Res; 2001 Jun; 493(1-2):115-26. PubMed ID: 11516721
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of co-mutagenic chlorinated harmans in final effluent from a sewage treatment plant.
    Fukazawa H; Matsushita H; Terao Y
    Mutat Res; 2001 Apr; 491(1-2):65-70. PubMed ID: 11287299
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Formation of DNA adducts by the co-mutagen norharman with aromatic amines.
    Mori M; Totsuka Y; Fukutome K; Yoshida T; Sugimura T; Wakabayashi K
    Carcinogenesis; 1996 Jul; 17(7):1499-503. PubMed ID: 8706255
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structural determination of a mutagenic aminophenylnorharman produced by the co-mutagen norharman with aniline.
    Totsuka Y; Hada N; Matsumoto K; Kawahara N; Murakami Y; Yokoyama Y; Sugimura T; Wakabayashi K
    Carcinogenesis; 1998 Nov; 19(11):1995-2000. PubMed ID: 9855015
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of norharman on the mutagenicity of toluidine metabolites.
    Gupta RL; Kaur IP; Gupta AK; Pathak DP; Juneja TR
    Toxicol Lett; 1989 Jul; 48(1):75-81. PubMed ID: 2665189
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantification of the co-mutagenic beta-carbolines, norharman and harman, in cigarette smoke condensates and cooked foods.
    Totsuka Y; Ushiyama H; Ishihara J; Sinha R; Goto S; Sugimura T; Wakabayashi K
    Cancer Lett; 1999 Sep; 143(2):139-43. PubMed ID: 10503893
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Harman and norharman induce SOS responses and frameshift mutations in bacteria.
    Oda Y; Nakamura S; Oki I
    Mutat Res; 1988 May; 208(1):39-44. PubMed ID: 3285203
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genotoxic effects of structurally related beta-carboline alkaloids.
    Picada JN; da Silva KV; Erdtmann B; Henriques AT; Henriques JA
    Mutat Res; 1997 Oct; 379(2):135-49. PubMed ID: 9357543
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Test-condition-dependent influence of harman and nonharman on benzo[a]pyrene mutagenesis in Salmonella.
    Riebe M; Westphal K; Keller H
    Mutat Res; 1982 Apr; 104(1-3):9-15. PubMed ID: 7043258
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mutagens formed from beta-carbolines with aromatic amines.
    Totsuka Y; Takamura-Enya T; Nishigaki R; Sugimura T; Wakabayashi K
    J Chromatogr B Analyt Technol Biomed Life Sci; 2004 Mar; 802(1):135-41. PubMed ID: 15036005
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Co-mutagenic effect of norharman with N-nitrosamine derivatives.
    Wakabayashi K; Nagao M; Kawachi T; Sugimura T
    Mutat Res; 1981 Jan; 80(1):1-7. PubMed ID: 7010130
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanism of appearance of mutagenicity of N-nitrosodiphenylamine with norharman.
    Wakabayashi K; Nagao M; Kawachi T; Sugimura T
    IARC Sci Publ; 1982; (41):695-707. PubMed ID: 7141576
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comutagenic effect of norharman with aminopyridine derivatives.
    Wakabayashi K; Yahagi T; Nagao M; Sugimura T
    Mutat Res; 1982 Oct; 105(4):205-10. PubMed ID: 7133029
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human exposure to mutagenic/carcinogenic heterocyclic amines and comutagenic beta-carbolines.
    Wakabayashi K; Totsuka Y; Fukutome K; Oguri A; Ushiyama H; Sugimura T
    Mutat Res; 1997 May; 376(1-2):253-9. PubMed ID: 9202762
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induction of sister chromatid exchanges and chromosome aberrations in cultured mammalian cells treated with aminophenylnorharman formed by norharman with aniline.
    Ohe T; Takata T; Maeda Y; Totsuka Y; Hada N; Matsuoka A; Tanaka N; Wakabayashi K
    Mutat Res; 2002 Mar; 515(1-2):181-8. PubMed ID: 11909766
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mutagenicities of mono-nitrobenzene derivatives in the presence of norharman.
    Suzuki J; Koyama T; Suzuki S
    Mutat Res; 1983 May; 120(2-3):105-10. PubMed ID: 6341826
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of norharman on the mutagenicity of chlorophenylhydroxylamine and its metabolism with rat liver S9.
    Suzuki J; Kobayashi Y; Monden S; Suzuki S
    Mutat Res; 1986 Sep; 162(2):165-72. PubMed ID: 3528827
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Norharman, an indoleamine-derived beta-carboline, but not Trp-P-2, a gamma-carboline, induces apoptotic cell death in human neuroblastoma SH-SY5Y cells.
    Uezono T; Maruyama W; Matsubara K; Naoi M; Shimizu K; Saito O; Ogawa K; Mizukami H; Hayase N; Shiono H
    J Neural Transm (Vienna); 2001; 108(8-9):943-53. PubMed ID: 11716147
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro and in vivo formation of aminophenylnorharman from norharman and aniline.
    Totsuka Y; Kataoka H; Takamura-Enya T; Sugimura T; Wakabayashi K
    Mutat Res; 2002 Sep; 506-507():49-54. PubMed ID: 12351144
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.